UAPR vs CURE

Comparison between Innovator U.S. Equity Ultra Buffer ETF - April (UAPR, ETF) and DIREXION DAILY HEALTHCARE BULL 3X SHARES (CURE, ETF).

5-Year PerformanceUAPR has outperformed CURE, delivering a return of +6.4% compared to +2.3%

UAPR vs CURE - Performance Comparison

Log

Key Characteristics

Financial metrics and valuation ratios

Metric	UAPR(ETF)	CURE(ETF)
Net Assets	$156M	$157M
Expense Ratio	0.79%	N/A
Max Drawdown	14.61%	69.19%
Sharpe Ratio	2.82	0.79
5Y Beta	0.42	1.38
P/E Ratio	N/A	28.04
Forward P/E	N/A	18.09
5Y Dividends CAGR	N/A	63.21%
5Y EPS CAGR	N/A	12.58%
Debt to Equity	N/A	53.58%
P/S Ratio	N/A	1.48
P/B Ratio	N/A	4.58

Net Assets

UAPR

$156M

Winner

CURE

$157M

Expense Ratio

UAPR

0.79%

CURE

N/A

Max Drawdown

Winner

UAPR

14.61%

CURE

69.19%

Sharpe Ratio

Winner

UAPR

2.82

CURE

0.79

5Y Beta

Winner

UAPR

0.42

CURE

1.38

P/E Ratio

UAPR

N/A

CURE

28.04

Forward P/E

UAPR

N/A

CURE

18.09

5Y Dividends CAGR

UAPR

N/A

CURE

63.21%

5Y EPS CAGR

UAPR

N/A

CURE

12.58%

Debt to Equity

UAPR

N/A

CURE

53.58%

P/S Ratio

UAPR

N/A

CURE

1.48

P/B Ratio

UAPR

N/A

CURE

4.58

UAPR vs CURE - Historical Returns

Returns include dividend reinvestment.

Period	UAPR	CURE
1 month	+0.15%	+22.71%
3 months	+5.39%	-2.64%
6 months	+7.01%	+3.17%
1 year	+13.05%	+35.83%
5 years(CAGR)	+6.41%	+2.35%
10 years(CAGR)	N/A	+13.12%
Max(CAGR)	+4.94%	+23.37%

UAPR

+0.15%

Winner

CURE

+22.71%

Winner

UAPR

+5.39%

CURE

-2.64%

Winner

UAPR

+7.01%

CURE

+3.17%

UAPR

+13.05%

Winner

CURE

+35.83%

5Y(CAGR)

Winner

UAPR

+6.41%

CURE

+2.35%

10Y(CAGR)

UAPR

N/A

CURE

+13.12%

Max(CAGR)

UAPR

+4.94%

Winner

CURE

+23.37%

UAPR vs CURE - Annual Returns (2011 - 2026)

Returns include dividend reinvestment.

Year	UAPR	CURE
2026	+6.18%	-7.73%
2025	+6.38%	+22.87%
2024	+12.50%	-12.90%
2023	+10.69%	-8.46%
2022	-5.59%	-17.91%
2021	+5.58%	+90.55%
2020	-5.32%	+4.13%
2019	+6.74%	+62.36%
2018	N/A	-0.75%
2017	N/A	+62.77%
2016	N/A	-12.42%
2015	N/A	+6.24%
2014	N/A	+83.03%
2013	N/A	+153.15%
2012	N/A	+45.79%
2011	N/A	-9.68%

UAPR vs CURE Drawdown Comparison

The maximum drawdown for UAPR was -14.61%, occurring on Apr 1, 2020. Recovery took 945 trading sessions.

The maximum drawdown for CURE was -69.19%, occurring on Mar 23, 2020. Recovery took 242 trading sessions.

The current UAPR drawdown is -0.72%. The current CURE drawdown is -25.85%.

Rank	UAPR	CURE
#1	-14.61% Feb 19, 2020 - Nov 17, 2023	-69.19% Jan 22, 2020 - Jan 6, 2021
#2	-10.84% Feb 19, 2025 - Aug 18, 2025	-52.25% Apr 8, 2022 - Aug 7, 2025
#3	-4.49% Jul 16, 2024 - Aug 21, 2024	-48.54% Jul 20, 2015 - Jun 22, 2017
#4	-3.23% Apr 29, 2019 - Jun 20, 2019	-44.44% Jul 1, 2011 - Mar 15, 2012
#5	-2.98% Mar 28, 2024 - May 15, 2024	-42.27% Oct 1, 2018 - Nov 27, 2019
#6	-2.75% Jul 26, 2019 - Sep 12, 2019	-36.35% Jan 26, 2018 - Sep 13, 2018
#7	-2.48% Aug 30, 2024 - Sep 19, 2024	-29.28% Dec 30, 2021 - Apr 8, 2022
#8	-1.77% Sep 12, 2019 - Oct 15, 2019	-22.89% Aug 17, 2021 - Dec 15, 2021
#9	-1.61% Dec 11, 2024 - Jan 17, 2025	-22.59% Sep 24, 2014 - Oct 28, 2014
#10	-1.35% Oct 22, 2024 - Nov 6, 2024	-19.78% Mar 4, 2014 - Jun 19, 2014
#11	-0.97% Oct 28, 2025 - Nov 25, 2025	-19.31% Oct 17, 2012 - Jan 9, 2013
#12	-0.91% May 21, 2024 - Jun 5, 2024	-19.31% Jan 20, 2021 - Apr 15, 2021
#13	-0.86% Nov 27, 2019 - Dec 12, 2019	-17.38% Apr 2, 2012 - Jun 29, 2012
#14	-0.81% Nov 13, 2024 - Nov 22, 2024	-15.49% May 28, 2013 - Jul 12, 2013
#15	-0.78% Jan 17, 2020 - Feb 5, 2020	-14.96% Dec 8, 2014 - Jan 22, 2015

Correlation

Correlation between UAPR and CURE is 0.39 which considered as a weak positive correlation - the stocks show a slight tendency to move together.

0.39

-101

Dividend Comparison (2011 - 2026)

UAPR vs CURE dividend yield comparison.

Year	UAPR	CURE
2026	0.00%	0.27%
2025	0.00%	1.12%
2024	0.00%	1.17%
2023	0.00%	2.02%
2022	0.00%	0.38%
2021	0.00%	0.02%
2020	0.00%	0.17%
2019	2.17%	0.40%
2018	0.00%	0.70%
2017	0.00%	0.18%
2013	0.00%	1.24%
2012	0.00%	0.03%
2011	0.00%	2.10%